A citation-based method for searching scientific literature

Brage Brakedal, Irene Flønes, Simone F Reiter, Øivind Torkildsen, Christian Dölle, Jörg Assmus, Kristoffer Haugarvoll, Charalampos Tzoulis. Mov Disord 2017
Times Cited: 67



Thomas Dehmer, Michael T Heneka, Magdalena Sastre, Johannes Dichgans, Jörg B Schulz. J Neurochem 2004
Times Cited: 313




List of shared articles



Times cited

Thiazolidinedione use is associated with reduced risk of Parkinson's disease in patients with diabetes: a meta-analysis of real-world evidence.
Salman Hussain, Ambrish Singh, Harveen Baxi, Bruce Taylor, John Burgess, Benny Antony. Neurol Sci 2020
12

Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications.
Marta Pajares, Ana I Rojo, Gina Manda, Lisardo Boscá, Antonio Cuadrado. Cells 2020
122

Pharmacological Targeting of Microglial Activation: New Therapeutic Approach.
Cai-Yun Liu, Xu Wang, Chang Liu, Hong-Liang Zhang. Front Cell Neurosci 2019
64

Neuroinflammation in Parkinson's Disease: Triggers, Mechanisms, and Immunotherapies.
Tai Wang, Changhe Shi, Haiyang Luo, Huimin Zheng, Liyuan Fan, Mibo Tang, Yun Su, Jing Yang, Chengyuan Mao, Yuming Xu. Neuroscientist 2022
3



Association of thiazolidinedione with a lower risk of Parkinson's disease in a population with newly-diagnosed diabetes mellitus.
Hsiu-Li Lin, Hsiu-Chen Lin, Yuan-Fu Tseng, Jane Chen-Jui Chao, Chien-Yeh Hsu. Ann Med 2018
8

Analysis of the Relationship between Type II Diabetes Mellitus and Parkinson's Disease: A Systematic Review.
Fauze Camargo Maluf, David Feder, Alzira Alves de Siqueira Carvalho. Parkinsons Dis 2019
23

Pioglitazone and statins lower incidence of Parkinson disease in patients with diabetes mellitus.
Y-Hu Chang, S-J Yen, Y-Ha Chang, W-J Wu, K-D Lin. Eur J Neurol 2021
8